Related references
Note: Only part of the references are listed.A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression
Debra D. Bloom et al.
CYTOTHERAPY (2015)
Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation
Philipp Nold et al.
CYTOTHERAPY (2015)
The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria
Jacques Galipeau et al.
CYTOTHERAPY (2015)
In Vivo Therapeutic Potential of Mesenchymal Stromal Cells Depends on the Source and the Isolation Procedure
Francesca Bortolotti et al.
STEM CELL REPORTS (2015)
Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation
Andreas Reinisch et al.
BLOOD (2015)
Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells
Marta Serafini et al.
STEM CELL RESEARCH (2014)
Cell Senescence Abrogates the Therapeutic Potential of Human Mesenchymal Stem Cells in the Lethal Endotoxemia Model
Juan Carlos Sepulveda et al.
STEM CELLS (2014)
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
Paolo Bianco et al.
NATURE MEDICINE (2013)
Clinical-Grade Mesenchymal Stromal Cells Produced Under Various Good Manufacturing Practice Processes Differ in Their Immunomodulatory Properties: Standardization of Immune Quality Controls
Cedric Menard et al.
STEM CELLS AND DEVELOPMENT (2013)
Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application
Cedric Menard et al.
STEM CELL RESEARCH & THERAPY (2013)
Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts
Sara M. Melief et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
Moira Francois et al.
CYTOTHERAPY (2012)
Human Dermis Harbors Distinct Mesenchymal Stromal Cell Subsets
Christine Vaculik et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Mesenchymal Stem Cells Inhibit Thymic Reconstitution After Allogeneic Cord Blood Transplantation
Michael Uhlin et al.
STEM CELLS AND DEVELOPMENT (2012)
Pooled MSCs for treatment of severe hemorrhage
O. Ringden et al.
BONE MARROW TRANSPLANTATION (2011)
The MSC: An Injury Drugstore
Arnold I. Caplan et al.
CELL STEM CELL (2011)
Endothelial Progenitor Cells: Quod Erat Demonstrandum?
Dirk Strunk
CURRENT PHARMACEUTICAL DESIGN (2011)
Immunomodulative Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells Cultured in Human Platelet Lysate
Antoinette Flemming et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Emerging therapeutic approaches for multipotent mesenchymal stromal cells
Paolo F. Caimi et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo
Andreas Reinisch et al.
BLOOD (2009)
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1
Venkata Lokesh Battula et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Isolation and Animal Serum Free Expansion of Human Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) and Endothelial Colony Forming Progenitor Cells (ECFCs)
Andreas Reinisch et al.
Jove-Journal of Visualized Experiments (2009)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum
Katharina Schallmoser et al.
TISSUE ENGINEERING PART C-METHODS (2008)
Clinical Protocols for the isolation and expansion of mesenchymal stromal cells
Karen Bieback et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2008)
Potential risks of bone marrow cell transplantation into infarcted hearts
Martin Breitbach et al.
BLOOD (2007)
Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells
Katharina Schallmoser et al.
TRANSFUSION (2007)
Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application
Andreas Reinisch et al.
REGENERATIVE MEDICINE (2007)
Stem cells: A revolution in therapeutics - Recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies
M. Mimeault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy
D Strunk et al.
TRANSFUSION (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors
JN Barker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Repair of large bone defects with the use of autologous bone marrow stromal cells
R Quarto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
